List of MeSH codes (C18)

The following is a partial list of the "C" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).

This list continues the information at List of MeSH codes (C17). Codes following these are found at List of MeSH codes (C19). For other MeSH codes, see List of MeSH codes.

The source for this content is the set of 2006 MeSH Trees from the NLM.

MeSH   C18 – nutritional and metabolic diseases

MeSH   C18.452 – metabolic diseases

MeSH   C18.452.076 – acid-base imbalance

• MeSH   C18.452.076.087 – achlorhydria
• MeSH   C18.452.076.176 – acidosis
• MeSH   C18.452.076.176.180 – acidosis, lactic
• MeSH   C18.452.076.176.210 – acidosis, renal tubular
• MeSH   C18.452.076.176.310 – acidosis, respiratory
• MeSH   C18.452.076.176.390 – diabetic ketoacidosis
• MeSH   C18.452.076.176.652 – ketosis
• MeSH   C18.452.076.354 – alkalosis
• MeSH   C18.452.076.354.271 – alkalosis, respiratory

MeSH   C18.452.090 – amyloidosis

• MeSH   C18.452.090.050 – amyloid neuropathies
• MeSH   C18.452.090.050.050 – amyloid neuropathies, familial
• MeSH   C18.452.090.075 – amyloidosis, familial
• MeSH   C18.452.090.075.050 – amyloid neuropathies, familial
• MeSH   C18.452.090.075.160 – cerebral amyloid angiopathy, familial
• MeSH   C18.452.090.100 – cerebral amyloid angiopathy
• MeSH   C18.452.090.100.160 – cerebral amyloid angiopathy, familial

MeSH   C18.452.100 – brain diseases, metabolic

• MeSH   C18.452.100.100 – brain diseases, metabolic, inborn
• MeSH   C18.452.100.100.050 – abetalipoproteinemia
• MeSH   C18.452.100.100.162 – carbamoyl-phosphate synthase I deficiency disease
• MeSH   C18.452.100.100.175 – citrullinemia
• MeSH   C18.452.100.100.320 – galactosemias
• MeSH   C18.452.100.100.355 – Hartnup disease
• MeSH   C18.452.100.100.360 – hepatolenticular degeneration
• MeSH   C18.452.100.100.365 – homocystinuria
• MeSH   C18.452.100.100.370 – hyperargininemia
• MeSH   C18.452.100.100.375 – hyperglycinemia, nonketotic
• MeSH   C18.452.100.100.380 – hyperlysinemias
• MeSH   C18.452.100.100.412 – Leigh disease
• MeSH   C18.452.100.100.425 – Lesch–Nyhan syndrome
• MeSH   C18.452.100.100.435 – lysosomal storage diseases, nervous system
• MeSH   C18.452.100.100.435.295 – fucosidosis
• MeSH   C18.452.100.100.435.340 – glycogen storage disease type II
• MeSH   C18.452.100.100.435.590 – mucolipidoses
• MeSH   C18.452.100.100.435.810 – sialic acid storage disease
• MeSH   C18.452.100.100.435.825 – sphingolipidoses
• MeSH   C18.452.100.100.435.825.200 – fabry disease
• MeSH   C18.452.100.100.435.825.300 – gangliosidoses
• MeSH   C18.452.100.100.435.825.300.300 – gangliosidoses GM2
• MeSH   C18.452.100.100.435.825.300.300.800 – Sandhoff disease
• MeSH   C18.452.100.100.435.825.300.300.840 – Tay–Sachs disease
• MeSH   C18.452.100.100.435.825.300.300.920 – Tay–Sachs disease, AB variant
• MeSH   C18.452.100.100.435.825.300.400 – gangliosidosis gm1
• MeSH   C18.452.100.100.435.825.400 – Gaucher disease
• MeSH   C18.452.100.100.435.825.590 – leukodystrophy, globoid cell
• MeSH   C18.452.100.100.435.825.594 – leukodystrophy, metachromatic
• MeSH   C18.452.100.100.435.825.700 – Niemann–Pick diseases
• MeSH   C18.452.100.100.520 – maple syrup urine disease
• MeSH   C18.452.100.100.535 – MELAS syndrome
• MeSH   C18.452.100.100.540 – Menkes kinky hair syndrome
• MeSH   C18.452.100.100.545 – MERRF syndrome
• MeSH   C18.452.100.100.640 – oculocerebrorenal syndrome
• MeSH   C18.452.100.100.650 – ornithine carbamoyltransferase deficiency disease
• MeSH   C18.452.100.100.680 – peroxisomal disorders
• MeSH   C18.452.100.100.680.100 – adrenoleukodystrophy
• MeSH   C18.452.100.100.680.760 – Refsum disease
• MeSH   C18.452.100.100.680.970 – Zellweger syndrome
• MeSH   C18.452.100.100.687 – phenylketonurias
• MeSH   C18.452.100.100.687.500 – phenylketonuria, maternal
• MeSH   C18.452.100.100.725 – pyruvate carboxylase deficiency disease
• MeSH   C18.452.100.100.750 – pyruvate dehydrogenase complex deficiency disease
• MeSH   C18.452.100.100.875 – tyrosinemias
• MeSH   C18.452.100.360 – hepatic encephalopathy
• MeSH   C18.452.100.480 – kernicterus
• MeSH   C18.452.100.540 – mitochondrial encephalomyopathies
• MeSH   C18.452.100.560 – myelinolysis, central pontine
• MeSH   C18.452.100.780 – Reye syndrome
• MeSH   C18.452.100.960 – Wernicke encephalopathy

MeSH   C18.452.174 – calcium metabolism disorders

• MeSH   C18.452.174.130 – calcinosis
• MeSH   C18.452.174.130.186 – calciphylaxis
• MeSH   C18.452.174.130.204 – CREST syndrome
• MeSH   C18.452.174.130.560 – nephrocalcinosis
• MeSH   C18.452.174.289 – decalcification, pathologic
• MeSH   C18.452.174.451 – hypercalcemia
• MeSH   C18.452.174.509 – hypocalcemia
• MeSH   C18.452.174.509.700 – tetany
• MeSH   C18.452.174.662 – osteomalacia
• MeSH   C18.452.174.766 – pseudohypoparathyroidism
• MeSH   C18.452.174.766.815 – pseudopseudohypoparathyroidism
• MeSH   C18.452.174.845 – rickets

MeSH   C18.452.284 – DNA repair-deficiency disorders

• MeSH   C18.452.284.060 – ataxia–telangiectasia
• MeSH   C18.452.284.100 – Bloom syndrome
• MeSH   C18.452.284.250 – Cockayne syndrome
• MeSH   C18.452.284.255 – colorectal neoplasms, hereditary nonpolyposis
• MeSH   C18.452.284.280 – fanconi anemia
• MeSH   C18.452.284.520 – Li–Fraumeni syndrome
• MeSH   C18.452.284.600 – Nijmegen breakage syndrome
• MeSH   C18.452.284.760 – Rothmund–Thomson syndrome
• MeSH   C18.452.284.800 – severe combined immunodeficiency
• MeSH   C18.452.284.960 – Werner syndrome
• MeSH   C18.452.284.975 – xeroderma pigmentosum

MeSH   C18.452.339 – dyslipidemias

• MeSH   C18.452.339.500 – hyperlipidemia
• MeSH   C18.452.339.500.396 – hypercholesterolemia
• MeSH   C18.452.339.500.396.300 – hypercholesterolemia, familial
• MeSH   C18.452.339.500.438 – hyperlipidemia, familial combined
• MeSH   C18.452.339.500.438.390 – hypercholesterolemia, familial
• MeSH   C18.452.339.500.438.395 – hyperlipoproteinemia type IV
• MeSH   C18.452.339.500.851 – hypertriglyceridemia
• MeSH   C18.452.339.750 – hyperlipoproteinemia
• MeSH   C18.452.339.750.475 – hypercholesterolemia, familial
• MeSH   C18.452.339.750.485 – hyperlipoproteinemia type III
• MeSH   C18.452.339.750.490 – hyperlipoproteinemia type IV
• MeSH   C18.452.339.750.495 – hyperlipoproteinemia type V
• MeSH   C18.452.339.750.552 – lipoprotein lipase deficiency, familial
• MeSH   C18.452.339.875 – hypolipoproteinemia
• MeSH   C18.452.339.875.220 – abetalipoproteinemia
• MeSH   C18.452.339.875.440 – hypobetalipoproteinemia
• MeSH   C18.452.339.875.448 – lecithin acyltransferase deficiency
• MeSH   C18.452.339.875.724 – tangier disease

MeSH   C18.452.394 – glucose metabolism disorders

• MeSH   C18.452.394.750 – diabetes mellitus
• MeSH   C18.452.394.750.074 – diabetes mellitus, experimental
• MeSH   C18.452.394.750.124 – diabetes mellitus, type 1
• MeSH   C18.452.394.750.124.960 – wolfram syndrome
• MeSH   C18.452.394.750.149 – diabetes mellitus, type 2
• MeSH   C18.452.394.750.149.500 – diabetes mellitus, lipoatrophic
• MeSH   C18.452.394.750.448 – diabetes, gestational
• MeSH   C18.452.394.750.535 – diabetic ketoacidosis
• MeSH   C18.452.394.750.774 – prediabetic state
• MeSH   C18.452.394.937 – glycosuria
• MeSH   C18.452.394.937.450 – glycosuria, renal
• MeSH   C18.452.394.952 – hyperglycemia
• MeSH   C18.452.394.952.500 – glucose intolerance
• MeSH   C18.452.394.968 – hyperinsulinism
• MeSH   C18.452.394.968.500 – insulin resistance
• MeSH   C18.452.394.968.500.570 – metabolic syndrome x
• MeSH   C18.452.394.968.750 – persistent hyperinsulinemia hypoglycemia of infancy
• MeSH   C18.452.394.984 – hypoglycemia
• MeSH   C18.452.394.984.492 – insulin coma
• MeSH   C18.452.394.984.746 – persistent hyperinsulinemia hypoglycemia of infancy

MeSH   C18.452.429 – hyperbilirubinemia

• MeSH   C18.452.429.124 – hyperbilirubinemia, neonatal
• MeSH   C18.452.429.124.500 – jaundice, neonatal
• MeSH   C18.452.429.500 – kernicterus

MeSH   C18.452.497 – hyperoxaluria

• MeSH   C18.452.497.490 – hyperoxaluria, primary

MeSH   C18.452.565 – iron metabolism disorders

• MeSH   C18.452.565.100 – anemia, iron-deficiency
• MeSH   C18.452.565.500 – iron overload
• MeSH   C18.452.565.500.480 – hemochromatosis
• MeSH   C18.452.565.500.500 – hemosiderosis

MeSH   C18.452.603 – malabsorption syndromes

• MeSH   C18.452.603.145 – blind loop syndrome
• MeSH   C18.452.603.250 – celiac disease
• MeSH   C18.452.603.506 – lactose intolerance
• MeSH   C18.452.603.850 – sprue, tropical
• MeSH   C18.452.603.887 – steatorrhea
• MeSH   C18.452.603.925 – whipple disease

MeSH   C18.452.648 – metabolism, inborn errors

• MeSH   C18.452.648.066 – amino acid metabolism, inborn errors
• MeSH   C18.452.648.066.102 – albinism
• MeSH   C18.452.648.066.102.090 – albinism, ocular
• MeSH   C18.452.648.066.102.100 – albinism, oculocutaneous
• MeSH   C18.452.648.066.102.100.400 – Hermansky–Pudlak syndrome
• MeSH   C18.452.648.066.102.600 – piebaldism
• MeSH   C18.452.648.066.187 – alkaptonuria
• MeSH   C18.452.648.066.210 – aminoaciduria, renal
• MeSH   C18.452.648.066.210.250 – cystinuria
• MeSH   C18.452.648.066.210.490 – Hartnup disease
• MeSH   C18.452.648.066.275 – carbamoyl phosphate synthase I deficiency disease
• MeSH   C18.452.648.066.340 – citrullinemia
• MeSH   C18.452.648.066.470 – homocystinuria
• MeSH   C18.452.648.066.475 – hyperargininemia
• MeSH   C18.452.648.066.477 – hyperglycinemia, nonketotic
• MeSH   C18.452.648.066.480 – hyperhomocysteinemia
• MeSH   C18.452.648.066.544 – hyperlysinemias
• MeSH   C18.452.648.066.608 – maple syrup urine disease
• MeSH   C18.452.648.066.620 – multiple carboxylase deficiency
• MeSH   C18.452.648.066.620.100 – biotinidase deficiency
• MeSH   C18.452.648.066.620.380 – holocarboxylase synthetase deficiency
• MeSH   C18.452.648.066.729 – ornithine carbamoyltransferase deficiency disease
• MeSH   C18.452.648.066.766 – phenylketonurias
• MeSH   C18.452.648.066.766.500 – phenylketonuria, maternal
• MeSH   C18.452.648.066.880 – tyrosinemias
• MeSH   C18.452.648.088 – amino acid transport disorders, inborn
• MeSH   C18.452.648.088.400 – hartnup disease
• MeSH   C18.452.648.088.600 – oculocerebrorenal syndrome
• MeSH   C18.452.648.100 – amyloidosis, familial
• MeSH   C18.452.648.100.050 – amyloid neuropathies, familial
• MeSH   C18.452.648.100.160 – cerebral amyloid angiopathy, familial
• MeSH   C18.452.648.151 – brain diseases, metabolic, inborn
• MeSH   C18.452.648.151.050 – abetalipoproteinemia
• MeSH   C18.452.648.151.162 – carbamoyl-phosphate synthase i deficiency disease
• MeSH   C18.452.648.151.168 – cerebral amyloid angiopathy, familial
• MeSH   C18.452.648.151.175 – citrullinemia
• MeSH   C18.452.648.151.300 – fucosidosis
• MeSH   C18.452.648.151.320 – galactosemias
• MeSH   C18.452.648.151.330 – glycogen storage disease type II
• MeSH   C18.452.648.151.355 – hartnup disease
• MeSH   C18.452.648.151.360 – hepatolenticular degeneration
• MeSH   C18.452.648.151.365 – homocystinuria
• MeSH   C18.452.648.151.370 – hyperargininemia
• MeSH   C18.452.648.151.375 – hyperglycinemia, nonketotic
• MeSH   C18.452.648.151.380 – hyperlysinemias
• MeSH   C18.452.648.151.412 – Leigh disease
• MeSH   C18.452.648.151.425 – Lesch–Nyhan syndrome
• MeSH   C18.452.648.151.435 – lysosomal storage diseases, nervous system
• MeSH   C18.452.648.151.435.295 – fucosidosis
• MeSH   C18.452.648.151.435.340 – glycogen storage disease type II
• MeSH   C18.452.648.151.435.590 – mucolipidoses
• MeSH   C18.452.648.151.435.810 – sialic acid storage disease
• MeSH   C18.452.648.151.435.825 – sphingolipidoses
• MeSH   C18.452.648.151.435.825.200 – Fabry disease
• MeSH   C18.452.648.151.435.825.300 – gangliosidoses
• MeSH   C18.452.648.151.435.825.300.300 – gangliosidoses GM2
• MeSH   C18.452.648.151.435.825.300.300.800 – Sandhoff disease
• MeSH   C18.452.648.151.435.825.300.300.840 – Tay–Sachs disease
• MeSH   C18.452.648.151.435.825.300.300.920 – Tay–Sachs disease, AB variant
• MeSH   C18.452.648.151.435.825.300.400 – gangliosidosis gm1
• MeSH   C18.452.648.151.435.825.400 – Gaucher disease
• MeSH   C18.452.648.151.435.825.590 – leukodystrophy, globoid cell
• MeSH   C18.452.648.151.435.825.594 – leukodystrophy, metachromatic
• MeSH   C18.452.648.151.435.825.700 – Niemann–Pick diseases
• MeSH   C18.452.648.151.445 – maple syrup urine disease
• MeSH   C18.452.648.151.447 – MELAS syndrome
• MeSH   C18.452.648.151.450 – menkes kinky hair syndrome
• MeSH   C18.452.648.151.505 – MERRF syndrome
• MeSH   C18.452.648.151.580 – mucolipidoses
• MeSH   C18.452.648.151.640 – oculocerebrorenal syndrome
• MeSH   C18.452.648.151.650 – ornithine carbamoyltransferase deficiency disease
• MeSH   C18.452.648.151.680 – peroxisomal disorders
• MeSH   C18.452.648.151.680.100 – adrenoleukodystrophy
• MeSH   C18.452.648.151.680.760 – refsum disease
• MeSH   C18.452.648.151.680.970 – Zellweger syndrome
• MeSH   C18.452.648.151.687 – phenylketonurias
• MeSH   C18.452.648.151.687.500 – phenylketonuria, maternal
• MeSH   C18.452.648.151.725 – pyruvate carboxylase deficiency disease
• MeSH   C18.452.648.151.750 – pyruvate dehydrogenase complex deficiency disease
• MeSH   C18.452.648.151.825 – sphingolipidoses
• MeSH   C18.452.648.151.825.200 – Fabry disease
• MeSH   C18.452.648.151.825.300 – gangliosidoses
• MeSH   C18.452.648.151.825.300.300 – gangliosidoses gm2
• MeSH   C18.452.648.151.825.300.300.700 – Sandhoff disease
• MeSH   C18.452.648.151.825.300.300.850 – Tay–Sachs disease
• MeSH   C18.452.648.151.825.300.300.925 – Tay–Sachs disease, AB variant
• MeSH   C18.452.648.151.825.300.400 – gangliosidosis gm1
• MeSH   C18.452.648.151.825.400 – Gaucher disease
• MeSH   C18.452.648.151.825.590 – leukodystrophy, globoid cell
• MeSH   C18.452.648.151.825.594 – leukodystrophy, metachromatic
• MeSH   C18.452.648.151.825.700 – Niemann–Pick diseases
• MeSH   C18.452.648.151.875 – tyrosinemias
• MeSH   C18.452.648.202 – carbohydrate metabolism, inborn errors
• MeSH   C18.452.648.202.125 – carbohydrate-deficient glycoprotein syndrome
• MeSH   C18.452.648.202.251 – fructose metabolism, inborn errors
• MeSH   C18.452.648.202.251.221 – fructose-1,6-diphosphatase deficiency
• MeSH   C18.452.648.202.251.271 – Hereditary fructose intolerance
• MeSH   C18.452.648.202.303 – fucosidosis
• MeSH   C18.452.648.202.355 – galactosemias
• MeSH   C18.452.648.202.449 – glycogen storage disease
• MeSH   C18.452.648.202.449.448 – glycogen storage disease type I
• MeSH   C18.452.648.202.449.500 – glycogen storage disease type II
• MeSH   C18.452.648.202.449.510 – glycogen storage disease type IIb
• MeSH   C18.452.648.202.449.520 – glycogen storage disease type III
• MeSH   C18.452.648.202.449.540 – glycogen storage disease type IV
• MeSH   C18.452.648.202.449.560 – glycogen storage disease type V
• MeSH   C18.452.648.202.449.580 – glycogen storage disease type VI
• MeSH   C18.452.648.202.449.600 – glycogen storage disease type VII
• MeSH   C18.452.648.202.449.620 – glycogen storage disease type VIII
• MeSH   C18.452.648.202.460 – hyperoxaluria, primary
• MeSH   C18.452.648.202.589 – lactose intolerance
• MeSH   C18.452.648.202.607 – mannosidase deficiency diseases
• MeSH   C18.452.648.202.607.500 – alpha-mannosidosis
• MeSH   C18.452.648.202.607.750 – beta-mannosidosis
• MeSH   C18.452.648.202.670 – mucolipidoses
• MeSH   C18.452.648.202.715 – mucopolysaccharidoses
• MeSH   C18.452.648.202.715.640 – mucopolysaccharidosis I
• MeSH   C18.452.648.202.715.645 – mucopolysaccharidosis II
• MeSH   C18.452.648.202.715.650 – mucopolysaccharidosis III
• MeSH   C18.452.648.202.715.655 – mucopolysaccharidosis IV
• MeSH   C18.452.648.202.715.670 – mucopolysaccharidosis VI
• MeSH   C18.452.648.202.715.675 – mucopolysaccharidosis VII
• MeSH   C18.452.648.202.720 – multiple carboxylase deficiency
• MeSH   C18.452.648.202.720.100 – biotinidase deficiency
• MeSH   C18.452.648.202.720.380 – holocarboxylase synthetase deficiency
• MeSH   C18.452.648.202.810 – pyruvate metabolism, inborn errors
• MeSH   C18.452.648.202.810.444 – Leigh disease
• MeSH   C18.452.648.202.810.666 – pyruvate carboxylase deficiency disease
• MeSH   C18.452.648.202.810.766 – pyruvate dehydrogenase complex deficiency disease
• MeSH   C18.452.648.240 – cytochrome-c oxidase deficiency
• MeSH   C18.452.648.390 – glucosephosphate dehydrogenase deficiency
• MeSH   C18.452.648.437 – hyperbilirubinemia, hereditary
• MeSH   C18.452.648.437.281 – Crigler–Najjar syndrome
• MeSH   C18.452.648.437.528 – gilbert disease
• MeSH   C18.452.648.499 – jaundice, chronic idiopathic
• MeSH   C18.452.648.556 – lipid metabolism, inborn errors
• MeSH   C18.452.648.556.475 – hypercholesterolemia, familial
• MeSH   C18.452.648.556.480 – hyperlipidemia, familial combined
• MeSH   C18.452.648.556.480.390 – hypercholesterolemia, familial
• MeSH   C18.452.648.556.480.395 – hyperlipoproteinemia type IV
• MeSH   C18.452.648.556.484 – hyperlipoproteinemia type III
• MeSH   C18.452.648.556.490 – hyperlipoproteinemia type IV
• MeSH   C18.452.648.556.495 – hyperlipoproteinemia type V
• MeSH   C18.452.648.556.500 – hypolipoproteinemia
• MeSH   C18.452.648.556.500.220 – abetalipoproteinemia
• MeSH   C18.452.648.556.500.440 – hypobetalipoproteinemia
• MeSH   C18.452.648.556.500.448 – lecithin acyltransferase deficiency
• MeSH   C18.452.648.556.500.724 – Tangier disease
• MeSH   C18.452.648.556.641 – lipoidosis
• MeSH   C18.452.648.556.641.201 – cholesterol ester storage disease
• MeSH   C18.452.648.556.641.391 – lipoidproteinosis
• MeSH   C18.452.648.556.641.509 – neuronal ceroid lipofuscinosis
• MeSH   C18.452.648.556.641.643 – Refsum disease
• MeSH   C18.452.648.556.641.723 – Sjögren–Larsson syndrome
• MeSH   C18.452.648.556.641.803 – sphingolipidoses
• MeSH   C18.452.648.556.641.803.300 – Fabry disease
• MeSH   C18.452.648.556.641.803.350 – gangliosidoses
• MeSH   C18.452.648.556.641.803.350.300 – gangliosidoses GM2
• MeSH   C18.452.648.556.641.803.350.300.700 – Sandhoff disease
• MeSH   C18.452.648.556.641.803.350.300.850 – Tay–Sachs disease
• MeSH   C18.452.648.556.641.803.350.300.925 – Tay–Sachs disease, AB variant
• MeSH   C18.452.648.556.641.803.350.360 – gangliosidosis gm1
• MeSH   C18.452.648.556.641.803.441 – Gaucher disease
• MeSH   C18.452.648.556.641.803.585 – leukodystrophy, globoid cell
• MeSH   C18.452.648.556.641.803.594 – leukodystrophy, metachromatic
• MeSH   C18.452.648.556.641.803.730 – Niemann–Pick diseases
• MeSH   C18.452.648.556.641.803.850 – sea-blue histiocyte syndrome
• MeSH   C18.452.648.556.641.923 – Wolman disease
• MeSH   C18.452.648.556.645 – lipoprotein lipase deficiency, familial
• MeSH   C18.452.648.556.750 – peroxisomal disorders
• MeSH   C18.452.648.556.750.025 – acatalasia
• MeSH   C18.452.648.556.750.112 – adrenoleukodystrophy
• MeSH   C18.452.648.556.750.200 – chondrodysplasia punctata, rhizomelic
• MeSH   C18.452.648.556.750.760 – Refsum disease
• MeSH   C18.452.648.556.750.970 – Zellweger syndrome
• MeSH   C18.452.648.556.850 – Smith–Lemli–Opitz syndrome
• MeSH   C18.452.648.556.925 – xanthomatosis, cerebrotendinous
• MeSH   C18.452.648.595 – lysosomal storage diseases
• MeSH   C18.452.648.595.201 – cholesterol ester storage disease
• MeSH   C18.452.648.595.554 – lysosomal storage diseases, nervous system
• MeSH   C18.452.648.595.554.295 – fucosidosis
• MeSH   C18.452.648.595.554.340 – glycogen storage disease type II
• MeSH   C18.452.648.595.554.590 – mucolipidoses
• MeSH   C18.452.648.595.554.810 – sialic acid storage disease
• MeSH   C18.452.648.595.554.825 – sphingolipidoses
• MeSH   C18.452.648.595.554.825.200 – Fabry disease
• MeSH   C18.452.648.595.554.825.300 – gangliosidoses
• MeSH   C18.452.648.595.554.825.300.300 – gangliosidoses GM2
• MeSH   C18.452.648.595.554.825.300.300.800 – Sandhoff disease
• MeSH   C18.452.648.595.554.825.300.300.840 – Tay–Sachs disease
• MeSH   C18.452.648.595.554.825.300.300.920 – Tay–Sachs disease, AB variant
• MeSH   C18.452.648.595.554.825.300.400 – gangliosidosis gm1
• MeSH   C18.452.648.595.554.825.400 – Gaucher disease
• MeSH   C18.452.648.595.554.825.590 – leukodystrophy, globoid cell
• MeSH   C18.452.648.595.554.825.594 – leukodystrophy, metachromatic
• MeSH   C18.452.648.595.554.825.700 – Niemann–Pick diseases
• MeSH   C18.452.648.595.577 – mannosidase deficiency diseases
• MeSH   C18.452.648.595.577.500 – alpha-mannosidosis
• MeSH   C18.452.648.595.577.750 – beta-mannosidosis
• MeSH   C18.452.648.595.600 – mucopolysaccharidoses
• MeSH   C18.452.648.595.600.640 – mucopolysaccharidosis I
• MeSH   C18.452.648.595.600.645 – mucopolysaccharidosis II
• MeSH   C18.452.648.595.600.650 – mucopolysaccharidosis III
• MeSH   C18.452.648.595.600.655 – mucopolysaccharidosis IV
• MeSH   C18.452.648.595.600.670 – mucopolysaccharidosis VI
• MeSH   C18.452.648.595.600.675 – mucopolysaccharidosis VII
• MeSH   C18.452.648.595.803 – sphingolipidoses
• MeSH   C18.452.648.595.803.300 – Fabry disease
• MeSH   C18.452.648.595.803.350 – gangliosidoses
• MeSH   C18.452.648.595.803.350.300 – gangliosidoses GM2
• MeSH   C18.452.648.595.803.350.300.700 – Sandhoff disease
• MeSH   C18.452.648.595.803.350.300.850 – Tay–Sachs disease
• MeSH   C18.452.648.595.803.350.300.925 – Tay–Sachs disease, AB variant
• MeSH   C18.452.648.595.803.441 – Gaucher disease
• MeSH   C18.452.648.595.803.585 – leukodystrophy, globoid cell
• MeSH   C18.452.648.595.803.594 – leukodystrophy, metachromatic
• MeSH   C18.452.648.595.803.730 – Niemann–Pick diseases
• MeSH   C18.452.648.595.803.850 – sea-blue histiocyte syndrome
• MeSH   C18.452.648.595.923 – Wolman disease
• MeSH   C18.452.648.618 – metal metabolism, inborn errors
• MeSH   C18.452.648.618.337 – hemochromatosis
• MeSH   C18.452.648.618.403 – hepatolenticular degeneration
• MeSH   C18.452.648.618.482 – hypophosphatasia
• MeSH   C18.452.648.618.544 – hypophosphatemia, familial
• MeSH   C18.452.648.618.590 – Menkes kinky hair syndrome
• MeSH   C18.452.648.618.711 – paralyses, familial periodic
• MeSH   C18.452.648.618.711.550 – hypokalemic periodic paralysis
• MeSH   C18.452.648.618.711.600 – paralysis, hyperkalemic periodic
• MeSH   C18.452.648.618.815 – pseudohypoparathyroidism
• MeSH   C18.452.648.618.815.815 – pseudopseudohypoparathyroidism
• MeSH   C18.452.648.730 – porphyria, erythropoietic
• MeSH   C18.452.648.735 – porphyrias, hepatic
• MeSH   C18.452.648.735.074 – coproporphyria, hereditary
• MeSH   C18.452.648.735.150 – porphyria, acute intermittent
• MeSH   C18.452.648.735.250 – porphyria cutanea tarda
• MeSH   C18.452.648.735.437 – porphyria, hepatoerythropoietic
• MeSH   C18.452.648.735.625 – porphyria, variegate
• MeSH   C18.452.648.735.812 – protoporphyria, erythropoietic
• MeSH   C18.452.648.769 – progeria
• MeSH   C18.452.648.798 – purine–pyrimidine metabolism, inborn errors
• MeSH   C18.452.648.798.368 – gout
• MeSH   C18.452.648.798.368.410 – arthritis, gouty
• MeSH   C18.452.648.798.594 – Lesch–Nyhan syndrome
• MeSH   C18.452.648.851 – renal tubular transport, inborn errors
• MeSH   C18.452.648.851.093 – acidosis, renal tubular
• MeSH   C18.452.648.851.191 – aminoaciduria, renal
• MeSH   C18.452.648.851.191.250 – cystinuria
• MeSH   C18.452.648.851.191.457 – Hartnup disease
• MeSH   C18.452.648.851.368 – cystinosis
• MeSH   C18.452.648.851.368.210 – Fanconi syndrome
• MeSH   C18.452.648.851.532 – glycosuria, renal
• MeSH   C18.452.648.851.647 – hypophosphatemia, familial
• MeSH   C18.452.648.851.750 – oculocerebrorenal syndrome
• MeSH   C18.452.648.851.770 – pseudohypoaldosteronism
• MeSH   C18.452.648.925 – steroid metabolism, inborn errors
• MeSH   C18.452.648.925.249 – adrenal hyperplasia, congenital
• MeSH   C18.452.648.925.500 – mineralocorticoid excess syndrome, apparent
• MeSH   C18.452.648.925.750 – ichthyosis, x-linked
• MeSH   C18.452.648.925.875 – Smith–Lemli–Opitz syndrome

MeSH   C18.452.660 – mitochondrial diseases

• MeSH   C18.452.660.195 – cytochrome-c oxidase deficiency
• MeSH   C18.452.660.300 – Friedreich's ataxia
• MeSH   C18.452.660.515 – optic atrophy, hereditary, leber
• MeSH   C18.452.660.520 – Leigh disease
• MeSH   C18.452.660.560 – mitochondrial myopathies
• MeSH   C18.452.660.560.620 – mitochondrial encephalomyopathies
• MeSH   C18.452.660.560.620.520 – MELAS syndrome
• MeSH   C18.452.660.560.620.530 – MERRF syndrome
• MeSH   C18.452.660.560.700 – ophthalmoplegia, chronic progressive external
• MeSH   C18.452.660.560.700.500 – Kearns–Sayre syndrome
• MeSH   C18.452.660.665 – optic atrophy, autosomal dominant
• MeSH   C18.452.660.705 – pyruvate carboxylase deficiency disease
• MeSH   C18.452.660.710 – pyruvate dehydrogenase complex deficiency disease

MeSH   C18.452.750 – phosphorus metabolism disorders

• MeSH   C18.452.750.400 – hypophosphatemia

MeSH   C18.452.872 – skin diseases, metabolic

• MeSH   C18.452.872.077 – adiposis dolorosa
• MeSH   C18.452.872.617 – porphyrias
• MeSH   C18.452.872.617.250 – porphyria, erythropoietic
• MeSH   C18.452.872.617.400 – porphyrias, hepatic
• MeSH   C18.452.872.617.400.074 – coproporphyria, hereditary
• MeSH   C18.452.872.617.400.150 – porphyria, acute intermittent
• MeSH   C18.452.872.617.400.250 – porphyria cutanea tarda
• MeSH   C18.452.872.617.400.437 – porphyria, hepatoerythropoietic
• MeSH   C18.452.872.617.400.625 – porphyria, variegate
• MeSH   C18.452.872.617.400.812 – protoporphyria, erythropoietic
• MeSH   C18.452.872.866 – xanthogranuloma, juvenile
• MeSH   C18.452.872.929 – xanthomatosis
• MeSH   C18.452.872.929.950 – wolman disease
• MeSH   C18.452.872.929.975 – xanthomatosis, cerebrotendinous

MeSH   C18.452.940 – wasting syndrome

• MeSH   C18.452.940.520 – hiv wasting syndrome

MeSH   C18.452.950 – water-electrolyte imbalance

• MeSH   C18.452.950.179 – dehydration
• MeSH   C18.452.950.340 – hypercalcemia
• MeSH   C18.452.950.396 – hyperkalemia
• MeSH   C18.452.950.452 – hypernatremia
• MeSH   C18.452.950.509 – hypocalcemia
• MeSH   C18.452.950.565 – hypokalemia
• MeSH   C18.452.950.620 – hyponatremia
• MeSH   C18.452.950.626 – inappropriate adh syndrome
• MeSH   C18.452.950.932 – water intoxication

MeSH   C18.654 – nutrition disorders

MeSH   C18.654.422 – infant nutrition disorders

• MeSH   C18.654.422.360 – hemorrhagic disease of newborn

MeSH   C18.654.521 – malnutrition

• MeSH   C18.654.521.500 – deficiency diseases
• MeSH   C18.654.521.500.133 – avitaminosis
• MeSH   C18.654.521.500.133.115 – ascorbic acid deficiency
• MeSH   C18.654.521.500.133.115.661 – scurvy
• MeSH   C18.654.521.500.133.628 – vitamin A deficiency
• MeSH   C18.654.521.500.133.699 – vitamin B deficiency
• MeSH   C18.654.521.500.133.699.160 – choline deficiency
• MeSH   C18.654.521.500.133.699.308 – folic acid deficiency
• MeSH   C18.654.521.500.133.699.529 – pellagra
• MeSH   C18.654.521.500.133.699.713 – riboflavin deficiency
• MeSH   C18.654.521.500.133.699.827 – thiamine deficiency
• MeSH   C18.654.521.500.133.699.827.223 – beriberi
• MeSH   C18.654.521.500.133.699.827.822 – wernicke encephalopathy
• MeSH   C18.654.521.500.133.699.901 – vitamin B6 deficiency
• MeSH   C18.654.521.500.133.699.923 – vitamin B12 deficiency
• MeSH   C18.654.521.500.133.699.923.280 – anemia, pernicious
• MeSH   C18.654.521.500.133.770 – vitamin D deficiency
• MeSH   C18.654.521.500.133.770.496 – osteomalacia
• MeSH   C18.654.521.500.133.770.734 – rickets
• MeSH   C18.654.521.500.133.841 – vitamin E deficiency
• MeSH   C18.654.521.500.133.841.682 – steatitis
• MeSH   C18.654.521.500.133.912 – vitamin K deficiency
• MeSH   C18.654.521.500.133.912.360 – hemorrhagic disease of newborn
• MeSH   C18.654.521.500.439 – magnesium deficiency
• MeSH   C18.654.521.500.617 – potassium deficiency
• MeSH   C18.654.521.500.708 – protein deficiency
• MeSH   C18.654.521.500.708.626 – protein-energy malnutrition
• MeSH   C18.654.521.500.708.626.505 – kwashiorkor
• MeSH   C18.654.521.500.857 – swayback
• MeSH   C18.654.521.625 – fetal nutrition disorders
• MeSH   C18.654.521.750 – starvation

MeSH   C18.654.726 – overnutrition

• MeSH   C18.654.726.500 – obesity
• MeSH   C18.654.726.500.695 – obesity hypoventilation syndrome
• MeSH   C18.654.726.500.700 – obesity, morbid
• MeSH   C18.654.726.500.740 – Prader–Willi syndrome

MeSH   C18.654.940 – wasting syndrome

• MeSH   C18.654.940.520 – hiv wasting syndrome

---

The list continues at List of MeSH codes (C19).